Resources

Between March and December 2010 this project Optimize study assessed the marginal managerial advantages of using a global system for mobile communications/short message service messaging to transmit the temperature data in 24 health centers of the district of Shkodra, Albania.

PATH’s Safe Water Project is implementing innovative methods to enable commercial enterprises to produce, distribute, sell, and maintain effective household water treatment and storage products for low-income populations in multiple developing countries around the world. This project brief summarizes the findings of PATH's work with the US Centers for Disease Control and Prevention to investigate the effects of an innovative program that promoted a chlorine disinfectant for treatment of water at home to pregnant women seeking antenatal care.

PATH’s Safe Water Project is implementing innovative methods to enable commercial enterprises to produce, distribute, sell, and maintain effective household water treatment and storage (HWTS) products for low-income populations in multiple developing countries around the world. This project brief and fact sheet summarize the findings of the bicycle entrepreneur distribution model—the first of a number of pilot projects that PATH and its partners undertook in India and other countries to overcome distribution and marketing barriers that make it difficult for HWTS manufacturers to reach lower-income households and rural markets.

Integration of health services—within communities, health organizations, broader health systems, and across sectors—is one way PATH works to improve global health. This overview brochure describes PATH's framework for health services integration, while four case studies provide specific examples of PATH's integration work.

This literature review details the key findings on the feasibility and acceptability of home delivery of depo-subQ provera 104™ in the Uniject™ injection system  (depo-subQ in Uniject). The review focused on self-injection and looked specifically at subcutaneous depot medroxyprogesterone acetate (DMPA) compared to the intramuscular formulation; considerations for home administration of injectable contraception, particularly in low-resource settings; and identified research needs for home administration, including self-injection, of depo-subQ in Uniject. A six-page briefing summary of this review is also available.